Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3073% above fair value
$319.11−1.51 (-0.47%)
Close on Nov 17, 2026Market cap $12.58BP/E 80.4Yield –
Penumbra operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Penumbra's operating cash flow for the twelve months ending Sep 30, 2026 was $261.05M, up 28.4% year over year. For fiscal 2025 it was $238.66M, up 41.7% from the year before. The highest annual figure on record is $238.66M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $238.66M | +41.7% |
| FY2024 | Dec 31, 2024 | $168.48M | +73.1% |
| FY2023 | Dec 31, 2023 | $97.33M | – |
| FY2022 | Dec 31, 2022 | -$55.66M | -685.8% |
| FY2021 | Dec 31, 2021 | $9.50M | – |
| FY2020 | Dec 31, 2020 | -$33.24M | -224.7% |
| FY2019 | Dec 31, 2019 | $26.65M | -7.5% |
| FY2018 | Dec 31, 2018 | $28.81M | +127.0% |
| FY2017 | Dec 31, 2017 | $12.69M | – |
| FY2016 | Dec 31, 2016 | -$12.81M | – |
| FY2015 | Dec 31, 2015 | -$20.69M | – |
| FY2014 | Dec 31, 2014 | -$6.39M | – |
| FY2013 | Dec 31, 2013 | -$3.40M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $41.51M | -28.8% |
| Q2 FY2026 | Jun 30, 2026 | $46.08M | +2.5% |
| Q1 FY2026 | Mar 31, 2026 | $86.97M | +77.6% |
| Q4 FY2025 | Dec 31, 2025 | $86.48M | +69.2% |
| Q3 FY2025 | Sep 30, 2025 | $58.26M | +3.2% |
| Q2 FY2025 | Jun 30, 2025 | $44.95M | +98.8% |
| Q1 FY2025 | Mar 31, 2025 | $48.97M | +27.9% |
| Q4 FY2024 | Dec 31, 2024 | $51.11M | +40.9% |
| Q3 FY2024 | Sep 30, 2024 | $56.47M | +83.1% |
| Q2 FY2024 | Jun 30, 2024 | $22.61M | +32.2% |
| Q1 FY2024 | Mar 31, 2024 | $38.30M | +191.7% |
| Q4 FY2023 | Dec 31, 2023 | $36.26M | +2612.1% |
| Q3 FY2023 | Sep 30, 2023 | $30.84M | – |
| Q2 FY2023 | Jun 30, 2023 | $17.10M | – |
| Q1 FY2023 | Mar 31, 2023 | $13.13M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.34M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.91M | -135.4% |
| Q2 FY2022 | Jun 30, 2022 | -$39.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.51M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.27M | – |
| Q3 FY2021 | Sep 30, 2021 | $36.45M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.31M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.37M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.08M | -143.7% |
| Q3 FY2020 | Sep 30, 2020 | -$3.55M | -116.1% |
| Q2 FY2020 | Jun 30, 2020 | -$21.69M | -1239.7% |
| Q1 FY2020 | Mar 31, 2020 | -$5.92M | – |
| Q4 FY2019 | Dec 31, 2019 | $4.77M | -36.7% |
| Q3 FY2019 | Sep 30, 2019 | $22.05M | +111.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.90M | +1434.7% |
| Q1 FY2019 | Mar 31, 2019 | -$2.07M | -119.3% |
| Q4 FY2018 | Dec 31, 2018 | $7.53M | – |
| Q3 FY2018 | Sep 30, 2018 | $10.45M | -2.9% |
| Q2 FY2018 | Jun 30, 2018 | $124.00K | -80.9% |
| Q1 FY2018 | Mar 31, 2018 | $10.71M | +388.1% |
| Q4 FY2017 | Dec 31, 2017 | -$907.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $10.75M | – |
| Q2 FY2017 | Jun 30, 2017 | $650.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $2.19M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.36M | – |
See a number that looks wrong?